about
An optimized isolation and labeling platform for accurate microRNA expression profiling.Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factorRAS is regulated by the let-7 microRNA familyThe colorectal microRNAomeIdentification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitroEvaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissuesHuman native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophagesPerformance and clinical evaluation of a sensitive multiplex assay for the rapid detection of common NPM1 mutationsThe KH-type RNA-binding protein PSI is required for Drosophila viability, male fertility, and cellular mRNA processing.Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development.Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR-ABL1 on the international reporting scale.Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate CytologyAccurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profilingDisruption of base-paired U4.U6 small nuclear RNAs induced by mammalian heterogeneous nuclear ribonucleoprotein C protein.Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.Recognition of exonic splicing enhancer sequences by the Drosophila splicing repressor RSF1Utility and cost-effectiveness of molecular testing in thyroid nodules with indeterminate cytology.Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations.Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation studyA multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.Modulation of P-element pre-mRNA splicing by a direct interaction between PSI and U1 snRNP 70K protein.Genome-wide analysis reveals an unexpected function for the Drosophila splicing factor U2AF50 in the nuclear export of intronless mRNAs.Efficiency versus effectiveness: impact of molecular testing on healthcare costs and clinical outcome of patients with indeterminate thyroid nodules.Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.Letter to the Editor: The Value of Molecular Testing for Effective Management of Patients With Indeterminate Thyroid Nodules.Do Pre-Analytical Parameters Explain KRAS Test Sensitivity Disparities?Asuragen IncMolecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimensmiRNA expression can classify pediatric thyroid lesions and increases the diagnostic yield of mutation testing
P50
Q24537470-8B3EA45E-336C-4CF0-A538-62FAB5DE7E04Q24548056-A212BDD8-0B5E-4231-9E9A-D7DD3106B639Q27860522-2724C4BA-F814-4FB5-A07A-55AFA7C0F878Q29616082-658A3AAF-7069-45AB-A49B-A4C70860E919Q30845060-8F119DCC-2329-4141-B51F-A7225855EBE6Q33327648-0D82D9CD-8B62-463D-89C8-5E4AE23B8793Q34084010-4F549A96-D69D-4B5F-9087-3E7507316148Q34084839-E658E3D5-183E-48D9-86D4-B68C6F8A5CFCQ35004838-293E2510-57EF-480C-A22D-43B7439BC030Q35191972-33E58BCB-25A1-4235-8470-640B0FF867ACQ35664358-E70AEFC8-1AF4-44E2-8B52-019D7AB7FC56Q35813259-A41F8564-12BE-4BA1-9254-DBF6919E060DQ36843220-C2EA2F6C-DD15-43A4-9EA4-AD44749DA520Q38293504-BE9621C1-04ED-4D12-93BC-DC8DE441AC3EQ38414023-876763CB-62BB-4DF3-9986-9025B83E6374Q39729988-233F0C56-A63A-426A-9A60-3D03FDA10884Q39786729-88B1919A-46FE-476A-AA98-7622D0DDD58BQ41199860-2D311689-A5A7-49C0-8F67-F532A00E2C6CQ41681180-FB6D4813-90C6-435B-ACE3-E571015377C7Q42010386-282497E0-5CB1-4787-9744-907DC6DFE7E5Q42255915-8880C12E-0A62-4561-B634-3299C37156BDQ43719393-E1A4BF8D-4B82-4926-A57E-6A354D33F95CQ45893684-35120D4F-0078-4ACA-932E-508F27484627Q45966339-3EE4F3AA-FA41-4EE3-896E-3312A16AE995Q46037903-AF89690E-DCA6-4006-AC9B-62FC6E9A42B8Q48198403-07450A9F-9BAD-45D4-BEF6-FF6B346FB09CQ50134829-FBAC0987-D27F-40B9-80C7-AEE9013E9382Q53114641-48EE4B69-27BA-49CF-8014-0A6F3ABC70AFQ54108273-2BC1850B-5C45-4E77-A404-F7C3C8E34747Q54216500-831825ED-FB9A-44E7-9AA0-BD86E5601B3EQ54380645-ED9F9C24-5DCD-4DA4-A1A6-765C80808083Q57636640-2ECDFEE4-2393-4A0E-B14A-40B689A0AAC3Q81383846-A4C045C0-7C40-4BA9-9448-0275939D57D9Q87881376-E03BA71D-7009-471D-80E2-D09006DE9D84Q90513867-CDAD3710-CC73-48C6-BC71-FAB448BC16DC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emmanuel Labourier
@ast
Emmanuel Labourier
@en
Emmanuel Labourier
@es
Emmanuel Labourier
@nl
Emmanuel Labourier
@sl
type
label
Emmanuel Labourier
@ast
Emmanuel Labourier
@en
Emmanuel Labourier
@es
Emmanuel Labourier
@nl
Emmanuel Labourier
@sl
altLabel
Manu
@en
prefLabel
Emmanuel Labourier
@ast
Emmanuel Labourier
@en
Emmanuel Labourier
@es
Emmanuel Labourier
@nl
Emmanuel Labourier
@sl
P106
P21
P31
P496
0000-0001-8010-0674